Inflammatory biomarkers as prognostic tools for diabetic retinopathy progression: a prospective study

Retinal Diseases

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand

Pediatr Diabetes

Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL

doi: 10.1155/2024/5893771

Retinal Diseases

Progression of diabetic retinopathy in a longitudinal real-world study of patients in primary care

BMC Ophthalmol

Lalwani G, Wykoff CC, Briggs J, Lin CY, Steffen V, Haskova Z

doi: 10.1186/s12886-025-04307-1

Macular DiseasesRetinal Diseases

Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy

Am J Ophthalmol

Viggiano P, Carra A, Bruno G, Boscia G, Pignataro MG, Termite AC, Borrelli E, Reibaldi M, Bacherini D, Alessio G, Parravano M, Boscia F

doi: 10.1016/j.ajo.2026.01.027

Retinal Diseases

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Diabetes Obes Metab

Lavens A, De Block C, Oriot P, Philips JC, Vandenbroucke M, Crenier L, Nobels F, Mathieu C, Belgian Group of Experts IQED

doi: 10.1111/dom.70049

Retinal Diseases

Diabetic retinopathy incidence, progression, and health-related quality of life from the ACCORD trial

Am J Ophthalmol

Prasad M, Agrón E, Vitale S, Arunachalam T, Duic C, Siddig F, Dimopoulos I, Lu A, Chew EY

doi: 10.1016/j.ajo.2025.07.018

Glaucoma and Ocular Pressure

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Ophthalmol Glaucoma

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y, SVF Prospector Study Group

doi: 10.1016/j.ogla.2025.04.009

Macular DiseasesRetinal Diseases

Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study

Ophthalmology

Shah J, Razavi P, Festok M, Ahmed H, Mahrous MA, Kovacs KD, Kiss S

doi: 10.1016/j.ophtha.2026.01.013

Retinal Diseases

The Association Between Diabetic Retinopathy Severity and Dementia Risk: A TriNetX Longitudinal Cohort Study

Am J Ophthalmol

Khangura MS, Spratt MA, Gao A, Manhapra A, Siegel NH, Chen X, Poulaki V, Ness S, Stein T, Subramanian ML

doi: 10.1016/j.ajo.2026.02.014

Retinal Diseases

Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy: A Prospective, Controlled Trial of 328 Eyes

Ophthalmol Retina

Manda A, Lee LH, Steinkerchner M, Sheng J, Veach L, Gangaputra S, Kim SJ

doi: 10.1016/j.oret.2025.06.014

Related content

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand

Progression of diabetic retinopathy in a longitudinal real-world study of patients in primary care

Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Diabetic retinopathy incidence, progression, and health-related quality of life from the ACCORD trial

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study

The Association Between Diabetic Retinopathy Severity and Dementia Risk: A TriNetX Longitudinal Cohort Study

Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy: A Prospective, Controlled Trial of 328 Eyes